
The Columbia-Suicide Severity Rating Scale (C-SSRS) is a semi-structured suicide risk assessment developed by Posner and colleagues at Columbia University, the University of Pennsylvania, and the University of Pittsburgh in 2011. It uses plain-language yes/no questions to measure four constructs — severity of ideation (1–5 ordinal scale), intensity of ideation, suicidal behavior, and lethality — to identify whether a person is at risk of suicide and the severity of that risk (Posner et al., 2011, American Journal of Psychiatry).
The C-SSRS has demonstrated strong convergent and divergent validity and high sensitivity and specificity for classifying suicidal behavior across adolescents and adults, and is endorsed by the FDA, CDC, and SAMHSA as a gold-standard suicide risk screener. Zentake's digital version auto-flags high-risk responses the moment a patient submits the form, so clinicians never miss a critical alert.
The C-SSRS uses binary (yes/no) responses across 10 categories covering suicidal ideation and behavior. The severity of ideation is rated on an ordinal scale from 1 (Wish to be Dead) to 5 (Active Ideation with Specific Plan and Intent). Any "yes" response to higher-severity ideation or behavior items indicates elevated risk and requires clinical follow-up.
Zentake automatically flags any "yes" response on Categories 3–5 or behavior items upon form submission, routing the alert to the assigned clinician in real time.
Step 1: Select the appropriate version. Choose between Screener, Full, Lifetime/Recent, or Since Last Visit based on your clinical workflow. Zentake hosts all validated versions in its template library.
Step 2: Deliver the form securely. Send the C-SSRS to patients via HIPAA-compliant link before or during the visit. Patients complete it on any device — no app download required.
Step 3: Walk through the questions in order. The C-SSRS is designed to be administered sequentially; patients answer ideation questions first, then behavior items.
Step 4: Review flagged responses immediately. Zentake surfaces high-risk answers at the top of the submission, enabling rapid triage and safety planning.
Step 5: Document and track over time. Longitudinal C-SSRS scores help you monitor risk trajectory and document clinical decision-making.
Scoring: Paper requires manual interpretation of each yes/no item; Zentake instantly identifies high-risk responses and categorizes severity.
Completion: Paper forms rely on in-office time; Zentake allows pre-visit completion on the patient's own device.
Delivery: Paper must be printed and handed out; Zentake sends HIPAA-compliant links by SMS or email.
Data Storage: Paper creates chart-room overhead; Zentake stores responses in an encrypted, audit-ready database.
Longitudinal Tracking: Paper makes trend analysis impossible; Zentake graphs risk trajectories across visits.
Security: Paper can be lost or misfiled; Zentake is end-to-end encrypted and HIPAA-compliant.
Integration: Paper requires manual EMR entry; Zentake syncs C-SSRS results directly into your EMR.
Cost: Paper consumes staff time and supplies; Zentake eliminates the administrative burden.
What does the C-SSRS measure?
The C-SSRS measures the severity and intensity of suicidal ideation, suicidal behavior, and lethality of attempts. It classifies risk across 10 yes/no categories and is used to identify patients at imminent risk of suicide. Zentake delivers the C-SSRS digitally and flags high-risk responses in real time.
How do you score the C-SSRS?
Scoring is based on binary (yes/no) responses. Severity of ideation ranges from 1 (wish to be dead) to 5 (active ideation with specific plan and intent). Any "yes" on ideation Categories 3–5 or behavior items indicates elevated risk. Zentake auto-calculates severity and highlights critical answers instantly.
How long does the C-SSRS take?
The Screener version takes 1–2 minutes; the Full version takes 5–10 minutes. Zentake's mobile-optimized form reduces completion time and eliminates manual scoring delay.
Is the C-SSRS free to use?
Yes, the C-SSRS is free for clinical, research, and institutional use through The Columbia Lighthouse Project. Zentake provides a pre-built digital version at no additional licensing cost.
What age or population is the C-SSRS for?
The C-SSRS is validated for ages 5 and up, with age-adapted versions for children, adolescents, and adults. It has been used in emergency rooms, outpatient clinics, schools, military, and primary care.
Who should administer the C-SSRS?
The C-SSRS can be administered by clinicians, nurses, social workers, teachers, and trained non-clinicians. Self-report versions are also validated. Zentake supports both self-administration and clinician-led workflows.
Is the C-SSRS FDA-recommended?
Yes — the C-SSRS is recommended by the FDA for assessing suicidal ideation and behavior in clinical trials and is endorsed by the CDC, SAMHSA, and the Joint Commission.
Last updated: March 2026